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Abstract 
 
This randomised single-blinded study was conducted to evaluate if there was any difference between spinal 
anaesthesia with hyperbaric bupivacaine 0.5% and intrathecal morphine 0.2mg and combined-spinal epidural using 
hyperbaric bupivacaine 0.5% with epidural infusion of bupivacaine 0.1% plus fentanyl 2.0µg/ml for 24 hours, 
postoperative analgesia following hip and knee arthroplasty, in terms of pain score and side effects (nausea, 
vomiting, pruritus and respiratory depression). Eighty patients ASA I or ASA II, aged between 18 to 75 years who 
underwent knee and hip arthroplasty of approximately 3-4 hours, duration were recruited. They were randomly 
allocated to one of two groups by using computer generated randomised numbers. The pain score during the 
postoperative period was evaluated using Visual Analogue Score (VAS pain score) and the side effects were 
documented and treated accordingly. Results showed that patients in Group 1 and Group 2 were comparable in terms 
of age, gender, height, weight and race. There was no statistical difference in VAS pain score between the two 
groups at all times intervals. However, patients in Group 1 had a higher incidence of nausea and pruritus than 
patients in Group 2. None of the patients in either group, experienced respiratory depression. Thus, it was concluded 
that both intrathecal morphine 0.2mg and epidural infusion of bupivacaine 0.1% plus fentanyl 2.0μg/ml were 
comparable in providing postoperative analgesia up to 24 hours following hip and knee arthroplasty. Nevertheless, 
the use of spinal morphine led to a higher incidence of side effects namely nausea and pruritus. 
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Introduction 
 
It is absolutely imperative that patients are not only 
adequately anaesthetized intraoperatively but should 
also receive adequate analgesia intraoperatively and 
postoperatively. Patients who receive adequate pain 
relief after surgery will recover and start mobilizing 
early, hence minimizing the risk of prolonged 
immobilization and hospital stay. Literature supports 
the relationship between the quality of the 
postoperative analgesia and the immediate functional 
outcome following major hip and knee surgery (1). 
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Similar to many modes of anaesthesia and analgesia 
intraoperatively, there are also numerous methods of 
providing analgesia postoperatively. Some of the 
commonly used methods include intrathecal or spinal 
anaesthesia, combined spinal-epidural (CSE), epidural 
analgesia, patient controlled analgesia (PCA), 
peripheral nerve blocks, subcutaneous and/or 
intramuscular opioids such as morphine or pethidine as 
well as oral, parenteral and suppository analgesia. As 
there are different techniques available, the choice of 
postoperative analgesia in each patient depends on 
many factors. For instance, patients subjected to lower 
limb surgery could be offered CSE. Combined spinal-
epidural anaesthesia is a combination of two 
anaesthetic procedures i.e. spinal and epidural 
anaesthesia which are performed together. It has been 
used increasingly over the last decade for anaesthesia 
as well as for postoperative analgesia (2). Another 
example is patients undergoing intra-abdominal 
surgery in which epidural analgesia can be 
administered. In both cases, these are methods of 
providing analgesia intraoperatively as well as 
postoperatively. Most commonly drugs used in 
epidural analgesia are pethidine (2.0mg/ml)-as a bolus 
and epidural infusion which consists of a combination 
of bupivacaine 0.1-0.2% plus fentanyl 2.0 µg/ml. 
Possible side effects include numbness of the lower 
limbs, pruritus, nausea, vomiting and a significant 
period of immobility which could lead to deleterious 
consequences such as deep venous thrombosis (3). 
 
Besides CSE and epidural infusion, intrathecal or 
spinal morphine has also been used to provide 
intraoperative and postoperative analgesia (4). 
Intrathecal morphine has been shown to offer effective 
analgesia in many surgical settings since the 
introduction of this technique into clinical practice in 
1979 (5). Several studies showed that intrathecal 
morphine can produce adequate analgesia in major 
orthopaedic and gynaecological procedures (3, 
5,6,7,8). 
 
Nevertheless, just as with other methods of 
postoperative analgesia, the use of intrathecal 
morphine is not without side effects, which limited its 
use in the earlier studies. Few of the common side 
effects include nausea and vomiting, pruritus, urinary 
retention and most importantly respiratory depression 
(3,9,10,11,12). One interesting point is that these 
earlier studies used intrathecal morphine doses as large 
as 2.5mg, which may have contributed to these side 
effects (6,13,14). The use of low dose intrathecal 
morphine (0.1 to 0.2mg) however produces no or 
minimal side effects, and at the same time offers 
effective analgesia to patients (10,15,16,17,18,19,20). 
This at the end leads to a high degree of patients’ 
satisfaction (9). 
 
Materials and Methods 
 
This was a randomised single blinded prospective 
study carried out on 80 patients after obtaining 
institutional approval. The sample size was calculated 
based on the anticipated success rate of 0.9 with the 
difference up to 0.2. In this calculation at least 40 
patients were required in each group to obtain a study 
power of 0.80 with the level of significance was 0.05 
(p<0.05). 
 
The subjects included ASA physical status I or II 
patients, aged 18 to 75 years old undergoing elective 
knee and hip arthroplasty, which were expected to last 
less than three hours. Exclusion criteria included any 
contraindication to central neuroaxial block and 
allergies to morphine and bupivacaine. In the 
operation theatres, they were randomly allocated to 
one of the groups (a single shot spinal anaesthesia or 
CSE) by using computer generated randomised 
numbers.  
 
Prior to the operation, all eligible patients were met in 
the ward a day earlier. They were informed thoroughly 
about the anaesthetic technique that would be 
administered to them, including the possible side 
effects. Explanation on the pain score was also given. 
At the end of the consultation, verbal as well as written 
consent were obtained from them. Patients were given 
oral midazolam 7.5mg as premedication. 
 
An 18 G branula was inserted at the patients’ hand and 
500ml of Hartman’s solution was given intravenously 
just prior to the induction of anaesthesia. Standard 
monitoring which included non-invasive blood 
pressure (NIBP), electrocardiogram (ECG) and pulse 
oximeter were applied to the patients. Intra-
operatively, the patients were prepared for spinal or 
CSE. The two anaesthetic techniques were done under 
aseptic technique at level of L3/L4. A single shot 
spinal anaesthesia was performed in Group 1 patients 
and they received 3.0 ml hyperbaric bupivacaine 0.5% 
plus 0.2mg morphine with 0.3 ml of normal saline 
(total volume 3.5 ml), administered intrathecally. 
Combined spinal-epidural anaesthesia was performed 
in Group 2 patients and they received 3.0 ml 
hyperbaric bupivacaine 0.5% with 0.5 ml of normal 
saline (total of 3.5 ml) given intrathecally and epidural 
infusion of bupivacaine 0.1% plus fentanyl 2.0μg/ml 
via epidural catheter (as part of a CSE technique) . 
 
Hypotension (defined as a systolic blood pressure of 
less than 80 mmHg) if any, was treated with fluids 
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(500ml of Hartmann’s solution) or vasopressor drug 
i.e. intravenous ephedrine in 3.0 mg increments until 
the blood pressure returned to normal. In the event 
where surgery unexpectedly lasted more than three 
hours, patients in Group1 were converted to general 
anaesthesia and thereby dropped from the study. 
 
Postoperatively, the patients were sent to the recovery 
bay and further monitoring was done before they were 
sent to their ward 30 minutes later. Epidural infusion 
of bupivacaine 0.1% plus fentanyl 2.0µg/ml at 
6.0ml/hour was started in Group 2 patients, on arrival 
at the recovery room and continued in the ward. In the 
ward, NIBP, HR and respiratory rate (RR) were 
monitored and observations were noted in the 
observation chart for every 8 hours during the 24 hours 
study period. The presence or absence of side effects 
i.e. nausea, vomiting, pruritus and respiratory 
depression (which is defined as patients taking eight 
breaths or less per minute) was also monitored every 
8hours interval during the 24 hours. Standard 
medications to treat side effects were administered 
when necessary. These included intravenous 
metoclopromide (maxolon) 10mg to treat vomiting, 
intravenous chlopheniramine (piriton) 10 mg for 
pruritus and intravenous naloxone 0.1mg for 
respiratory depression. 
 
Pain scores during the postoperative period was 
evaluated using the VAS pain scores, where the degree 
of pain was numbered from 0 (no pain at all) to 10 
(highest pain). A VAS pain score of 3 or less will be 
interpreted as patients not having any significant 
postoperative pain at rest. 
 
In the event where the patients’ score was four or 
more, patients were treated accordingly. Patients in 
Group 1 were given an additional intravenous 
tramadol (tramal) 50mg to overcome the pain while 
patients in Group 2 were given a bolus of epidural 
lignocaine 2% 5.0ml and at the same time the epidural 
infusion rate increased by 2.0ml/hour.  
 
Data was analysed by using the SPSS statistic package 
(version 12). As the sample size was not normally 
distributed, Mann-Whitney and chi-squared test were 
used for non-parametric data. A value of p<0.05 was 
regarded as statistically significant. 
 
Results  
 
There was no marked difference between the two 
groups in term of age, gender, height, weight and race 
(Table 1). 
 
 
Table 1: Patients demographic data. Values expressed as 
median (minimum-maximum) unless stated otherwise. 
 
 Group 1 
(n=40) 
Group 2 
(n=40) 
Age (years) 50 (16-70) 42 (16-75) 
Gender*      
  Male 
  Female                                                    
 
29 (72.5) 
11 (27.5)
 
16 (40) 
24 (60) 
Height (cm) 170 (155-180) 165 (148-180) 
Weight (kg) 65 (40-88) 60 (38-89) 
Race*  
  Malay 
  Chinese 
  Indian 
 
26 (65) 
13 (32.5) 
1 (2.5) 
 
23 (57.5) 
12 (30) 
5 (12) 
*denotes total number + percentage in bracket for that 
category 
 
Table 2: VAS pain score. Values expressed as numbers (n) 
 
Time 
interval 
VAS pain 
score* 
Group 1 
(n=40) 
Group 2 
(n=40) 
‘p’ 
value 
8 hours 4-10 
0-3 
1 
39 
2 
38 
1.000 
16 hours 
 
4-10 
0-3 
1 
39 
2 
38 
1.000 
24 hours 4-10 
0-3 
0 
40 
2 
38 
0.494 
*VAS pain score: 0-3 (no pain), 4-10 (pain) 
 
In this analysis, those scored between 0 and 3 were 
categorized as having no pain while those of 4 and 10 
were categorized as having pain. There was no 
statistical difference in VAS pain score between the 
two groups at all intervals with p>0.05 in all categories 
(Table 2).  
 
Pruritus was present only in Group 1 and though 
occurring at all intervals, was only statistically 
significant at 8 and 16 hours. Nausea was present in 
Group 1 at 8 and 16 hours postoperatively, none in 
Group 2 and the difference was statistically significant 
between the two groups. None of the patients required 
treatment. Three patients in Group 1had vomiting at 8 
hours interval which did not require treatment and the 
difference between the two groups were not 
significant. None of the patients in Group 2 developed 
pruritus, nausea or vomiting. None of the patients in 
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Table 3: Number of patients with pruritus, nausea and 
vomiting. Values expressed as numbers (n) and percentage 
in bracket. 
 
Side 
Effects 
Time 
Interval 
(hours) 
Group 1 
(n=40) 
Group 2 
(n=40) 
‘p’ value 
Pruritus 8 
16 
24 
30 (75) 
13 (32.5) 
3 (7.5) 
0 
0 
0 
0.000 
0.000 
0.239 
 
Nausea 
8 
16 
24 
15 (37.5) 
10 (25) 
0 
0 
0 
0 
0.000 
0.000 
 
Vomiting 8 
16 
24 
3 (7.5) 
0 
0 
0 
0 
0 
0.239 
 
 
 
both groups developed respiratory depression (Table 
3). There was no hypotension and no patients required 
intravenous tramadol or boluses of epidural lignocaine. 
 
Discussion 
 
One of the challenging tasks for anaesthetists is to 
offer adequate analgesia to patients as a mean of 
providing early ambulatory to hasten their 
rehabilitation. Capdevila et al. reported that regional 
techniques (epidural or spinal anaesthesia) improved 
early rehabilitation after major hip and knee surgery 
(1). 
 
Spinal anaesthesia using local anaesthetic and 
morphine was introduced 29 years ago. However, its 
use was limited due to its side effects such as nausea, 
vomiting, pruritus and respiratory depression (8). 
When an opioid is administered intrathecally, it 
simultaneously travels cephalad within the 
cerebrospinal fluid (CSF) and then enters the spinal 
cord and binds to nonspecific sites within the white 
matter or specific opioid receptors within the dorsal 
horn to give its effect (analgesia). It can also 
transverse the dura mater and enter the epidural space 
where it binds to epidural fat, and then enters the 
plasma compartment through vascular uptake and 
cause side effects (11). 
 
Anaesthesia for total hip and knee arthroplasty should 
provide adequate intraoperative and postoperative 
analgesia with minimum side effects. Spinal 
anaesthesia, epidural anaesthesia and CSE using 
bupivacaine with or without opioid offer more benefits 
as they provide adequate and prolonged postoperative 
analgesia. However, these techniques are commonly 
associated with unwanted side effects such as nausea, 
vomiting, pruritus and respiratory depression (3,21) 
 
Not many studies compared spinal anaesthesia with 
heavy bupivacaine 0.5% and intrathecal morphine 
0.2mg was superior to CSE using bupivacaine 0.5% 
combined with epidural infusion of bupivacaine 0.1% 
plus fentanyl 2.0μg/ml for postoperative analgesia 
after hip and knee arthroplasty. However, studies 
related to the use of intrathecal morphine, epidural 
infusion of bupivacaine with or without fentanyl, 
epidural morphine and epidural pethidine for 
postoperative pain relief following major surgical 
procedures other than hip and knee arthroplasty had 
been highlighted by few investigators. 
 
In this study, we performed spinal anaesthesia and 
intrathecal morphine (0.2mg) was used for 
postoperative analgesia for hip and knee arthorplasty. 
Earlier studies did show that low doses of intrathecal 
morphine provided good analgesia after major 
arthroplasty. This included a study by Murphy et al. 
compared various doses of intrathecal morphine (0.05, 
0.1 and 0.2mg) in 60 patients aged above 65 years 
undergoing elective hip arthroplasty. He concluded 
that 0.1mg intrathecal morphine provided the best 
balance between analgesia and side effect profiles 
(10). 
 
Jacobson et al. also studied various intrathecal 
morphine doses (0.3, 1.0, 2.5mg) for postoperative 
analgesia in 33 who patients underwent total hip and 
knee replacement surgery and concluded that doses 
between 0.1 and 0.3mg offered good analgesia with 
minimal side effects (15). Rathmell et al. and Hassett 
et al. found that 0.2 and 0.3 mg morphine given 
intrathecally produced satisfactory pain control after 
knee and hip arthroplasty (7,20). Another study 
performed by Souron et al. also concluded that 0.1mg 
intrathecal morphine provided better postoperative 
analgesia than single short psoas compartment block 
after primary hip arthroplasty (14). A recent study 
conducted by Damevski et al. showed that intrathecal 
morphine 0.05 and 0.1mg provided optimal 
postoperative pain relief without side effects for 
patients undergoing total knee arthroplasty. However, 
this technique was supplemented by giving continuous 
3-in-1 nerve block plus femoral PCA bupivacaine 
boluses (19). Therefore, it can be concluded that the 
dose between 0.1 and 0.3 provided adequate 
postoperative analgesia for hip and knee arthroplasty.  
 
Besides intrathecal morphine, single shot epidural 
anaesthesia with bupivacaine 0.5% combined with 
morphine 0.1-0.2mg provided a synergistic analgesic 
effect and was found to be suitable for postoperative 
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pain relief after major orthopaedic surgery (21,22). 
Leclerc et al. and Stulberg et al. noted that continuous 
epidural anaesthesia by infusion had been considered 
as the techniques of choice for postoperative pain 
relief in patients undergoing hip and knee arthroplasty 
(23,24). It was shown that epidural infusion using 
bupivacaine 0.1% with fentanyl 2.0µg/ml (epidural 
infusion dose given was similar to our study) provided 
good pain relief, reduces intraoperative blood loss and 
incidence of deep vein thrombosis. However, 
unwanted side effects such as nausea and vomiting, 
pruritus, sedation urinary retention and respiratory 
depression had been observed (23,24). 
 
Maheswari et al. used a local anaesthetic epidural 
infusion with and without patient-controlled epidural 
analgesia for 24 hours (25). They found many patients 
suffered rebound pain. They also tried combinations of 
epidural infusion with femoral nerve block, with or 
without intravenous PCA. All these techniques were 
associated with side effects that included respiratory 
depression, nausea, vomiting, ileus, urinary retention, 
pruritus, hypotension, bradycardia, and cognitive 
changes (25). 
 
Continuous low-dose epidural infusion had been 
advocated as a method to control postoperative pain 
for hip surgery by Indelli et al. (26). This technique 
allowed pain relief to be more precisely titrated to the 
level of pain stimulus and could be discontinued if 
problems occur (26). Although epidural infusion 
provided superior analgesia but it was associated with 
hypotension, ileus, urinary retention and mild motor 
block (22,27). 
 
There were mixed results in terms of side effects from 
these two techniques. Pruritus and nausea were 
statistically significant in Group 1 at 8 and 16 hours 
interval, respectively. However, the incidence of 
vomiting and respiratory depression at all intervals 
were not statistically significant in this study. 
 
Pruritus is one of the unwanted effects of intrathecal 
morphine (3,7,12,15,16). The incidence of pruritus 
after intrathecal administration of opioids varies from 
30% to 100%, nevertheless the exact mechanism of 
neuroaxial opioid-induced pruritus remains unclear 
(16). Postulated hypotheses included the presence of 
an ‘itch centre’ in the central nervous system, 
medullary dorsal horn activation, antagonism of 
inhibitory transmitters, modulation of serotonergic 
pathway and involvement of prostaglandins (11). 
 
Rathmell et al. (7) and Murphy et al. (10) in their 
studies showed that pruritus was more frequent with 
intrathecal morphine 0.2 mg. A study by Slappender et 
al. showed that pruritus occurred even at low dose of 
intrathecal morphine (12). Pietri et al. used intrathecal 
morphine 0.2 mg as a method of postoperative 
analgesia for patients undergoing liver resection and 
found the incidence of pruritus was around 16% (28). 
In this study 75% of patients in the intrathecal 
morphine group experienced pruritus at the 8thhour 
interval as compared to 0% in the combine spinal-
epidural group. 
 
Apart from pruritus, nausea and vomiting are also side 
effects of intrathecal morphine. It maybe a systemic 
effect versus cephalad migration in CSF and 
interaction with opioid receptors in the area postrema 
(11). Gwitz et al. noted 25% incidence of nausea and 
vomiting with intrathecal morphine doses ranging 
from 0.2 to 0.8mg (8). Pietri et al. reported the overall 
incidence of nausea (16%) and vomiting (4%) when 
using intrathecal morphine 0.2 mg (28). In our study 
we used a similar dose but the results were slightly 
different (37.5% and 7.5% of patients in Group 1 
experienced nausea and vomiting respectively at 8th 
hour interval). However, Weber et al. carried out a 
study using 0.2 mg of intrathecal morphine and 
showed no relationship between the use of intrathecal 
morphine and the high incidence of nausea and 
vomiting (16). 
 
The most feared side effect of intrathecal morphine is 
respiratory depression (4,11,20). This occurs when a 
hydrophilic opioid like morphine transverses slowly 
from the CSF to the spinal cord and epidural space 
slowly hence respiratory depression can persist for 18-
24 hours (11). The true incidence of clinically 
significant respiratory depression however remains 
unknown. Rathmell et al. mentioned the risk of 
respiratory depression after intrathecal morphine was 
less than 1% (11). Gwirtz et al. revealed a 3% 
incidence using 0.2 to 0.8 mg of intrathecal morphine, 
however this number represented only ‘a potential 
risk’ rather than the true respiratory depression (8). 
Sarkowska et al. found that out of 79 patients received 
intrathecal morphine, only one patient (1.2%) 
developed respiratory depression (29). A study done 
by Duale et al. showed that intrathecal morphine 0.075 
mg given in pregnant women was effective in 
providing postoperative analgesia after caesarean 
section without causing respiratory depression (30). 
Hassett et al. used 0.1 and 0.2 mg intrathrecal 
morphine for total knee arthroplasty and found that 
there were no differences between patients with regard 
to nausea, vomiting, pruritus and respiratory 
depression (20). In this study none of the patients in 
Group 1 developed respiratory depression. This could 
be attributed to low dose morphine used (0.2 mg).  
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Alternative anaesthetic techniques should be sought to 
avoid spinal morphine-induced pruritus and vomiting. 
Spinal anaesthesia with a peripheral nerve block has 
been used for postoperative analgesia post hip and 
knee arthroplasty. Study done by Barrington et al. (31) 
on patients underwent knee arthroplasty under spinal 
anesthesia and received either a femoral infusion of 
bupivacaine 0.2% or an epidural infusion of 
ropivacaine 0.2% with fentanyl 4.0 μg/ml. Results 
showed that an equivalent pain relief between the two 
groups but there was significantly less nausea, 
vomiting and pruritus in the femoral infusion group 
(31). Spinal anaesthesia using hyperbaric bupivacaine 
0.5% with a femoral, lumbosacral plexus or fascia 
iliaca block using hyperbaric bupivacaine or 
ropivacaine 0.75% had been shown to provide good 
quality of analgesia without pruritus. In these cases, 
the peripheral nerve to be blocked was located 
accurately by using ultrasound-guided device 
(32,33,34). The other technique was local infiltration 
analgesia using ropivacaine 0.75% plus adrenaline. 
The drugs were infiltrated in the knee during operation 
and two bolus injections of same mixture were given 
via an intraarticular catheter postoperatively (35,36). 
Therefore, the use of intrathecal morphine should be 
avoided to reduce side effects and improve patient 
safety.   
 
Conclusion 
 
This study showed that intrathecal morphine 0.2 mg 
and epidural infusion of bupivacaine 0.1% plus 
fentanyl 2.0 µg/ml were equally effective in providing 
postoperative analgesia for up to 24 hours for hip and 
knee arthroplasty. 
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